Understanding treatment outcomes for older adults with overactive bladder
Determinants of outcomes for older and frail older adults with refractory overactive bladder
This study is looking at how older adults with overactive bladder respond to new treatments, like injections and nerve stimulation, to find out which options work best and are safest for them, so they can get the right care for their needs.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10912086 on NIH RePORTER |
What this research studies
This research investigates how older and frail adults respond to advanced treatments for overactive bladder, specifically focusing on therapies like onabotulinumtoxinA, peripheral tibial nerve stimulation, and sacral neuromodulation. The study aims to identify the effectiveness and potential complications of these treatments in this vulnerable population, which has been underrepresented in previous research. By analyzing treatment outcomes, the researchers hope to develop a personalized prognostic tool that can guide better treatment decisions for older patients. This approach seeks to ensure that older adults receive appropriate care tailored to their specific health needs.
Who could benefit from this research
Good fit: Ideal candidates for this research are older and frail adults experiencing refractory overactive bladder.
Not a fit: Patients who are younger or do not have overactive bladder may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and outcomes for older adults suffering from overactive bladder.
How similar studies have performed: Previous research has shown success in understanding treatment outcomes in younger populations, but this approach is novel for older adults.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Suskind, Anne M. — University of California, San Francisco
- Study coordinator: Suskind, Anne M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.